Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2025 Oct 7;15:34876. doi: 10.1038/s41598-025-16303-y

Modeling the transmission dynamics of Mpox virus

Sani Rabiu 1,2,, Majid Khan Majahar Ali 1,
PMCID: PMC12504446  PMID: 41057369

Abstract

The global emergence of human monkeypox (Mpox) necessitates stage-structured transmission models. We develop a compartmental framework with Prodromal, Rash, and Complication stages, identifying critical thresholds through bifurcation analysis. A transcritical bifurcation at Inline graphic dayInline graphic separates stable disease-free equilibrium (Inline graphic) from endemic spread. Normalized sensitivity analysis establishes transmission rate Inline graphic (Inline graphic) as the dominant epidemic driver, with mortality Inline graphic (Inline graphic) and progression rate Inline graphic (Inline graphic) as key modulators. Intervention analysis reveals: (1) 22.7% outbreak reduction (95% CI: 19.4–25.1%) through prodromal case isolation (days 0-5) requiring 92% diagnostic accuracy; (2) Linear Inline graphic response to transmission controls (0.0398 reduction per 10% Inline graphic decrease); (3) Phase-adaptive resource allocation (60% to transmission reduction) sustains subcritical operation. The framework advocates real-time Inline graphic monitoring via wastewater surveillance and Inline graphic-optimized diagnostics.

Keywords: Mpox Virus, Transmission Dynamics, Compartmental Model, Epidemiological Modeling, Infectious Diseases

Subject terms: Mathematics and computing, Applied mathematics

Introduction

Monkeypox (Mpox) is an emerging zoonotic viral disease caused by the Mpox virus, belonging to the Orthopoxvirus genus, which also includes the variola virus responsible for smallpox1. First identified in 1958 in laboratory monkeys, Mpox has garnered increased global attention due to recent outbreaks beyond its endemic regions in Africa, primarily driven by human-to-human transmission2. The disease is transmitted through close contact with bodily fluids, skin lesions, or contaminated surfaces, with transmission dynamics similar to those of other orthopoxviruses3. The clinical manifestation of Mpox includes fever, malaise, lymphadenopathy, and a characteristic rash that progresses through several stages before recovery or death in severe cases4,5. Monkeypox can occur in individuals of any age, progressing through three distinct stages: incubation, prodrome, and the eruptive phase69. The initial infection may not always be easy to pinpoint, particularly in cases of zoonotic transmission. On average, the incubation period lasts around 13 days but can range from 3 to 34 days. Following this, the prodromal stage typically persists for 1 to 4 days and is marked by symptoms such as fever, headaches, exhaustion, and frequently swollen lymph nodes, particularly in the neck, jaw areas and infectious10. Recent outbreaks have renewed interest in understanding the transmission dynamics and potential control strategies through mathematical modeling. Mathematical models, especially compartmental models, have been widely used to understand and predict the spread of infectious diseases. Compartmental models such as the SEIR (Susceptible-Exposed-Infectious-Recovered) framework have proven effective in capturing key epidemiological features and guiding public health interventions11,12. Mpox, compartmental models can be extended to include additional stages such as Prodromal, Rash, Complications, and Death to more accurately reflect the progression of the disease13. This study develops a compartmental model for Mpox, incorporating key epidemiological compartments that represent different stages of infection and outcomes. The model is constructed to account for the zoonotic nature of Mpox, human-to-human transmission, and the potential for severe complications.

Literature review

In recent years, mathematical modeling has proven to be a valuable tool in understanding the spread of infectious diseases, including Mpox. The use of compartmental models to simulate the dynamics of infectious diseases has a long history, dating back to the early 20th century with Kermack and McKendrick’s seminal work on the SIR model14,15. These models have been extensively used in epidemiology to capture the dynamics of various infectious diseases by dividing the population into different classes based on their health status16,17. Since then, these models have evolved to accommodate more complex disease dynamics, such as latency periods, varying transmission rates, and multi-host systems, making them essential tools in epidemiology18. The approach helps in estimating key parameters such as transmission rates, recovery rates, and the impact of interventions on the epidemic’s progression. Extension of these model, such as the SEIR (Susceptible-Exposed-Infectious-Recovered) and SEIRS models, account for additional stages in disease progression, such as the latent or incubation period19. The models have been instrumental in shaping public health policies by simulating potential outcomes under various scenarios of disease transmission and intervention strategies. Mpox, caused by the monkeypox virus, has recently gained attention due to its re-emergence in certain parts of the world. The disease shares similarities with smallpox, yet it has distinct epidemiological features that require tailored modeling approaches20. Various studies have employed compartmental models to describe the dynamics of Mpox. Several studies have extended the basic SEIR framework to include multiple compartments2123, reflecting the progression of symptoms and severity in viral diseases such as Ebola, SARS, and Mpox itself24. Early models of Mpox outbreaks in Africa, where the virus is endemic, primarily used the SEIR framework to simulate transmission dynamics25. These models typically included compartments for susceptible, exposed, infectious, and recovered individuals, capturing the basic epidemiological dynamics26. However, as more data on Mpox became available, particularly from outbreaks in non-endemic regions, the need for more detailed models that include additional stages of disease progression became apparent. The 2022 Mpox outbreak, which spread to multiple countries outside of Africa, spurred a wave of new research into the transmission dynamics and potential interventions for Mpox. Several studies have used real-time data from this outbreak to refine existing models and provide projections on the outbreak’s trajectory under different intervention scenarios27,28. Models incorporating quarantine, isolation, and vaccination strategies have provided valuable insights for public health authorities in managing these outbreaks. Additionally, researchers have explored the role of asymptomatic transmission and super-spreading events in driving Mpox outbreaks, which have implications for modeling efforts29,30. In the context of understanding Mpox virus transmission dynamics, the study by25 provides valuable insights through the development of an SEIR-based deterministic model, which incorporates the prodromal stage, differential infectivity, and hospitalization. This model is instrumental in enhancing control interventions, as it computes key epidemiological metrics like the basic reproduction number (Inline graphic) to estimate the potential spread of infections in a fully susceptible population. The study further investigates the stability of equilibrium states to assess the virus’s transmission potential and utilizes sensitivity analysis, specifically the partial rank correlation coefficient, to identify the most influential parameters for disease control. Numerical simulations and model predictions offer additional evaluation of how critical parameters affect the prevention and containment of Mpox outbreaks, strengthening public health strategies31. investigated the impact of imperfect vaccination, primarily derived from the Smallpox vaccine, on the spread of the Mpox virus. Their results suggest that while these vaccines do not provide complete immunity, they still play a crucial role in reducing transmission. Lowering the rate of new infections, even imperfect vaccines can significantly slow the spread of Mpox within a population, thereby contributing to more effective control strategies32. developed a mathematical deterministic model that captures the dynamics of Monkeypox by considering both human and rodent populations. While recent studies advance understanding of Mpox control strategies33,32, they often overlook the stage-specific transmission dynamics intrinsic to Mpox progression. Clinically, Mpox evolves through three phases: incubation, prodromal (high temperature, headache, fatigue, and often, lymphadenopathy, especially in the cervical and maxillary regions), and eruptive (rash/lesions)34,35, with transmission risks escalating dramatically during the rash phase due to high viral loads in pustular fluids36. Existing models frequently aggregate transmission into a single infectious compartment37, obscuring the distinct epidemiological roles of prodromal (Inline graphic) and rash (Inline graphic) stages. To address this gap, we propose a SEPRRvC model (Susceptible-Exposed-Prodromal-Rash-Recovered-Complications) with two key innovations:

  1. Stage-separated force of infection: The total force of infection Inline graphic explicitly captures contributions from both Prodromal (Inline graphic) and Rash (Inline graphic) compartments. While the transmission rate Inline graphic is constant, the model acknowledges that Inline graphic contributes disproportionately to transmission due to higher viral shedding in lesions38.

  2. Phase-dependent interventions: Isolating Inline graphic and Inline graphic compartments, the model evaluates targeted strategies (e.g., early detection during prodromal vs. strict isolation during rash).

The model further incorporates a Complications (C) compartment (Eq. 1) to quantify severe outcomes39, aligning with WHO guidelines for stage-specific case management40. This structure enables precise evaluation of public health measures, such as:

  • Optimizing testing during the prodromal window (low infectivity but critical for containment).

  • Scaling isolation capacity during the eruptive surge (high infectivity).

The force of infection Inline graphic in Eq. 1 reflects empirical evidence that:

  • Prodromal transmission (Inline graphic) usually 1–4 days41,42,39,43.

  • Rash-stage transmission (Inline graphic) dominates (Inline graphic) due to lesion-driven viral shedding and cover 14 to 28 days36.

Separating Inline graphic and Inline graphic, the model avoids conflating their transmission roles a limitation of single-infectious-compartment frameworks25. The structure of the paper is as follows: Section 1 provides the introduction, followed by Section 2, which presents the literature review. Section 3 details the methodology, while Section 4 discusses the results and analysis. Finally, Section 5 concludes the paper.

Methodology

The methodology employs a compartmental modeling approach to investigate the transmission dynamics of Monkeypox (Mpox). This model extends the SEIR framework by stratifying the infectious phase into Prodromal (P) and Rash (R) compartments, capturing distinct clinical stages with differing transmission potentials as shown in Fig. 1. The inclusion of Complications (C) further enables analysis of severe outcomes, providing a holistic representation of Mpox progression44.

Fig. 1.

Fig. 1

Flowchart of Mpox Dynamics.

Model formulation

The population is divided into six compartments:

  • Susceptible (S): Individuals at risk of Mpox. Infection occurs via contact with Prodromal (P) or Rash (R) individuals at rate Inline graphic. Dynamics include birth (Inline graphic) and natural death (Inline graphic).

  • Exposed (E): Infected but not yet infectious. Transition to P occurs at rate Inline graphic.

  • Prodromal (P): Early symptomatic stage (fever, lymphadenopathy) with low viral shedding. While individuals in Inline graphic are mildly infectious, clinical studies suggest their contribution to transmission is minimal (Inline graphic2–5% of total cases)45. Transition to R (Inline graphic), recover (Inline graphic), or die (Inline graphic).

  • Rash (R): High-transmission stage characterized by rash/lesions, contributing Inline graphic90–98% of infections due to elevated viral shedding38. Recover (Inline graphic), develop complications (Inline graphic), or die (Inline graphic).

  • Recovered (Inline graphic): Lifelong immunity is assumed post-recovery. Inflows originate from Inline graphic (Inline graphic), Inline graphic (Inline graphic), and Inline graphic (Inline graphic).

  • Complications (C): Severe cases (e.g., secondary infections, sepsis) with prolonged hospitalization. Recovery occurs at rate Inline graphic; death occurs at rate Inline graphic.

graphic file with name d33e764.gif 1

Parameter descriptions

The epidemiological parameters in the model are defined as follows:

  • Inline graphic: Recruitment rate into the susceptible population (persons/day)

  • Inline graphic: Transmission rate of Mpox disease (dayInline graphic)

  • Inline graphic: Natural mortality rate (dayInline graphic)

  • Inline graphic: Progression rate from exposed to prodromal stage (dayInline graphic)

  • Inline graphic: Disease-induced mortality rate in complications (dayInline graphic)

  • Inline graphic: Progression rate from prodromal to rash stage (dayInline graphic)

  • Inline graphic: Recovery rate directly from prodromal stage (dayInline graphic)

  • Inline graphic: Recovery rate from rash stage (dayInline graphic)

  • Inline graphic: Recovery rate from complications (dayInline graphic)

  • Inline graphic: Complication development rate from rash stage (dayInline graphic)

Model dynamics and biological assumptions

The model incorporates the following biologically-motivated assumptions:

  1. Transmission Mechanism: The force of infection Inline graphic accounts only for transmission from prodromal (P) and rash (R) compartments, excluding complications (C) based on clinical evidence:
    1. Individuals in the prodromal stage (P) exhibit early symptoms (fever, lymphadenopathy) while maintaining community mobility, enabling transmission through close contact.
    2. Rash-stage individuals (R) develop characteristic skin lesions containing high viral loads, representing peak infectiousness through direct contact and fomites.
    3. Complications (C) represent severe cases (hemorrhagic manifestations, sepsis, encephalitis) typically requiring hospitalization and isolation, substantially reducing transmission risk. This aligns with clinical management protocols that isolate severe cases within 48 hours of complication onset. This exclusion is supported by epidemiological studies of orthopoxviruses indicating <2% secondary transmission from hospitalized cases compared to community cases45,46.
  2. Compartment-Specific Mortality:
    1. Natural mortality (Inline graphic): Affects all compartments equally, representing background mortality.
    2. Disease-induced mortality (Inline graphic): Exclusive to complications (C) compartment, capturing elevated mortality risk from severe manifestations like secondary infections and sepsis.
  3. Transition Dynamics:
    1. Stage progression: Follows exponential distributions with mean durations:
      graphic file with name d33e1009.gif
    2. Recovery pathways:
      • i.
        Direct recovery from prodromal stage (γ2)
      • ii.
        Recovery from rash stage (δ1)
      • iii.
        Recovery from complications (δ2)
  4. Population Dynamics:
    1. Non-negative populations: All compartments satisfy Inline graphic for Inline graphic given non-negative initial conditions.
    2. Total population:
      graphic file with name d33e1069.gif 2
      evolves according to:
      Inline graphic
      reflecting both natural and disease-induced mortality.
    3. Lifelong immunity: Recovered individuals (Inline graphic) retain permanent immunity against reinfection, consistent with orthopoxvirus immunology47.
  5. Justification for Exclusion of C in Inline graphic Calculation: The basic reproduction number Inline graphic quantifies secondary infections generated by a single typical infectious individual in a fully susceptible population. Our exclusion of the complications compartment (C) from Inline graphic calculation is based on three principal considerations:
    1. Transmission potential: Clinical studies indicate viral loads in severe cases are comparable to earlier stages, but infection control measures in healthcare settings reduce transmission opportunities by 85-95% compared to community settings.
    2. Epidemiological significance: During the initial invasion phase when Inline graphic is calculated, complications develop after mean duration Inline graphic days (Table 1), while serial intervals for Mpox are 8-12 days. Thus, complication-derived transmission occurs too late to significantly influence Inline graphic.
    3. Compartmental contribution: Sensitivity analysis shows C contributes <2% to overall transmission force in endemic equilibrium (Fig. 3), justifying its exclusion from Inline graphic calculation without significantly altering threshold estimates. The next-generation matrix approach accordingly considers EPR as infected compartments for Inline graphic derivation, while C is excluded from transmission dynamics but included in disease progression and mortality calculations.

Fig. 3.

Fig. 3

Time-series simulation under disease-free equilibrium conditions (Inline graphic). Initial conditions: Inline graphic, Inline graphic, Inline graphic.

Theorem 1

(Boundedness of the Total Population) Under the dynamics described by the system of differential equations in (1), the total population Inline graphic, as defined in (2), remains bounded for all Inline graphic.

Proof

To establish the boundedness of Inline graphic, note that the total population Inline graphic at any time Inline graphic is given as:

graphic file with name d33e1238.gif

Taking the time derivative of Inline graphic:

graphic file with name d33e1251.gif

Substituting the updated system of equations (1):

graphic file with name d33e1260.gif

Simplifying by canceling terms:

graphic file with name d33e1266.gif

Since Inline graphic, Inline graphic, Inline graphic, and Inline graphic, we have:

graphic file with name d33e1297.gif
graphic file with name d33e1302.gif 3

Thus, the solution Inline graphic is bounded for Inline graphic, and the total population Inline graphic is bounded above by Inline graphic. Inline graphic

Computation of the basic reproduction number Inline graphic

The infectious compartments are Inline graphic, Inline graphic, and Inline graphic, with the state vector:

graphic file with name d33e1367.gif

System of equations for infectious compartments

From the model equations, the dynamics of the infectious compartments are:

graphic file with name d33e1376.gif

At the Disease-Free Equilibrium (DFE), Inline graphic, and Inline graphic, so the total population is Inline graphic.

Next-generation matrix

Using the next-generation matrix method, we decompose the system into new infections (Inline graphic) and transitions (Inline graphic).

Infection Matrix Inline graphic: The new infection terms are:

graphic file with name d33e1426.gif

The Jacobian of Inline graphic with respect to Inline graphic is:

graphic file with name d33e1444.gif

Transition Matrix Inline graphic: The transition terms are:

graphic file with name d33e1459.gif

The Jacobian of Inline graphic with respect to Inline graphic is:

graphic file with name d33e1477.gif

The next-generation matrix is Inline graphic. The inverse Inline graphic is:

graphic file with name d33e1496.gif

Multiplying Inline graphic by Inline graphic:

graphic file with name d33e1514.gif

The basic reproduction number Inline graphic is the spectral radius (dominant eigenvalue) of Inline graphic. Simplifying the dominant eigenvalue:

graphic file with name d33e1533.gif

This accounts for transmission from both the prodromal (Inline graphic) and rash (Inline graphic) stages, weighted by their respective residence times and infectivity.

Theorem 2

(Existence and Characterization of Equilibrium Points) The system of differential equations in (1) admits two types of equilibrium points:

  • Disease-Free Equilibrium (DFE):
    graphic file with name d33e1562.gif
  • Endemic Equilibrium (EE):
    graphic file with name d33e1570.gif

Proof

To determine the equilibrium points, set all time derivatives in (1) to zero:

graphic file with name d33e1582.gif

Disease-Free Equilibrium (DFE): Set Inline graphic. Solving gives:

graphic file with name d33e1594.gif

Thus, Inline graphic, and the endemic Equilibrium (EE) exist in (4) for Inline graphic. Inline graphic

graphic file with name d33e1623.gif 4

Theorem 3

(Local Stability of Equilibrium Points) Define:

graphic file with name d33e1634.gif

where Inline graphic is:

graphic file with name d33e1646.gif

The stability of equilibrium points is characterized as follows:

  1. Disease-Free Equilibrium (DFE): The DFE is locally asymptotically stable if Inline graphic and unstable if Inline graphic.

  2. Endemic Equilibrium (EE): If Inline graphic, the EE is locally asymptotically stable.

Proof

  1. Disease-Free Equilibrium (DFE): The Jacobian at Inline graphic is:
    graphic file with name d33e1696.gif
    The characteristic polynomial is found by solving Inline graphic. Through block matrix decomposition and determinant properties, we obtain:
    graphic file with name d33e1708.gif
    where:
    graphic file with name d33e1714.gif
    with coefficients:
    graphic file with name d33e1721.gif
    where Inline graphic, Inline graphic, Inline graphic, and Inline graphic.

Trivial eigenvalues: Inline graphic (double root), Inline graphic

Routh-Hurwitz Criteria For a cubic polynomial Inline graphic, the necessary and sufficient conditions for all roots to have negative real parts are:

  • (i)

    Inline graphic

  • (ii)

    Inline graphic

  • (iii)

    Inline graphic

  1. Coefficient Positivity:
    • Inline graphic (all Inline graphic)
    • Inline graphic
    • Inline graphic
  2. Determinant Condition:
    graphic file with name d33e1841.gif
  3. All Routh-Hurwitz conditions satisfied. DFE is locally asymptotically stable If Inline graphic.

  • 2.
    Endemic Equilibrium (EE): The Jacobian at Inline graphic is:
    graphic file with name d33e1869.gif

where:

graphic file with name d33e1875.gif

The eigenvalues of Inline graphic are roots of the characteristic polynomial:

graphic file with name d33e1888.gif

The characteristic polynomial is:

graphic file with name d33e1894.gif

where:

graphic file with name d33e1900.gif

and

graphic file with name d33e1906.gif

By Routh-Hurwitz Criteria since coefficients Inline graphic and the Hurwitz determinants Inline graphic are satisfied. Inline graphic

Theorem 4

(Global Stability of Equilibria in the SEPRRvC Model) Consider the SEPRRvC model governed by the system in (1) with positive parameters Inline graphic, and total population (2) bounded as per Theorem 1.

  • Disease-Free Equilibrium (DFE): If Inline graphic, the DFE Inline graphic is globally asymptotically stable (GAS) in the feasible region.

  • Endemic Equilibrium (EE): If Inline graphic, the unique endemic equilibrium Inline graphic defined in (4) is GAS in the interior of the feasible region.

Proof

Global Stability of the DFE (Inline graphic)

Define the Lyapunov function:

graphic file with name d33e2001.gif

This function is positive definite in the infected compartments and vanishes only at the DFE. The time derivative is:

graphic file with name d33e2007.gif

Simplifying the expression:

graphic file with name 41598_2025_16303_Equ84_HTML.gif

Since Inline graphic (from Theorem 1), we have Inline graphic, and:

graphic file with name d33e2033.gif

Thus:

graphic file with name d33e2039.gif

Substituting the expression for Inline graphic:

graphic file with name d33e2051.gif

When Inline graphic, Inline graphic with equality if and only if Inline graphic. When Inline graphic, the system dynamics imply:

graphic file with name d33e2082.gif

By LaSalle’s Invariance Principle, all trajectories converge to Inline graphic. Thus, the DFE is GAS when Inline graphic.

Global Stability of the EE (Inline graphic)

We prove GAS of the endemic equilibrium Inline graphic using Lyapunov function. Define the Lyapunov function:

graphic file with name d33e2118.gif

The time derivative is:

graphic file with name d33e2124.gif
graphic file with name d33e2129.gif 5
graphic file with name d33e2135.gif 6
graphic file with name d33e2141.gif 7
graphic file with name d33e2147.gif 8
graphic file with name d33e2153.gif 9
graphic file with name d33e2160.gif 10
graphic file with name d33e2166.gif 11
graphic file with name d33e2172.gif 12
graphic file with name d33e2178.gif 13

Using the system equations and equilibrium conditions eqs. (5) to (12), we compute each term:

graphic file with name d33e2191.gif

Step 1: Compute Each Term

Term 1: Inline graphic

From the system, Inline graphic. Using (5), Inline graphic, we get:

graphic file with name d33e2224.gif

Thus:

graphic file with name d33e2230.gif

Simplify:

graphic file with name d33e2237.gif

For the Inline graphic terms:

graphic file with name d33e2249.gif

Thus:

graphic file with name d33e2255.gif

The term Inline graphic, since Inline graphic, Inline graphic, and Inline graphic.

Term 2: Inline graphic

From the system, Inline graphic. Using (6), Inline graphic, so:

graphic file with name d33e2312.gif

Thus:

graphic file with name d33e2318.gif

So:

graphic file with name d33e2325.gif

Term 3: Inline graphic

From the system, Inline graphic. Using (7), Inline graphic, so:

graphic file with name d33e2355.gif

Thus:

graphic file with name d33e2361.gif

So:

graphic file with name d33e2368.gif

Term 4: Inline graphic

From the system, Inline graphic. Using (8), Inline graphic, so:

graphic file with name d33e2398.gif

Thus:

graphic file with name d33e2404.gif

So:

graphic file with name d33e2411.gif

Term 5: Inline graphic

From the system, Inline graphic. Using (10), Inline graphic, so:

graphic file with name d33e2442.gif

Thus:

graphic file with name d33e2448.gif

So:

graphic file with name d33e2455.gif

Term 6: Inline graphic

From the system, Inline graphic. Using (9), Inline graphic, so:

graphic file with name d33e2485.gif

Since Inline graphic, we have:

graphic file with name d33e2498.gif

The term involving Inline graphic:

graphic file with name d33e2510.gif

Step 2: Combine Terms

Summing all terms:

graphic file with name d33e2519.gif

Step 3: Simplify Infection Terms

Since from Inline graphic from 3, so Inline graphic. Define Inline graphic, Inline graphic. Using (6), Inline graphic. The infection terms are:

graphic file with name d33e2565.gif

Rewrite:

graphic file with name d33e2571.gif

Step 4: Rewrite Transition Terms

For the transition terms, rewrite each to form Inline graphic:

- Inline graphic:

graphic file with name d33e2594.gif

Add and subtract Inline graphic:

graphic file with name d33e2606.gif

- Inline graphic:

graphic file with name d33e2619.gif

- Inline graphic:

graphic file with name d33e2631.gif

- Inline graphic:

graphic file with name d33e2643.gif

Thus:

graphic file with name d33e2649.gif

Since Inline graphic, and all coefficients are positive, Inline graphic, with equality only when Inline graphic, Inline graphic, Inline graphic, Inline graphic, Inline graphic, Inline graphic. Inline graphic

Table 1.

Epidemiological Parameters and Sources.

Parameter Description (Units) Value Source
Inline graphic Recruitment rate (persons/day) 9832.97 48
Inline graphic Natural mortality rate (dayInline graphic) 0.018 49
Inline graphic Transmission rate (dayInline graphic) 0.06 49
Inline graphic ExposedInline graphicProdromal rate (dayInline graphic) 0.02 50
Inline graphic ProdromalInline graphicRash rate (dayInline graphic) 0.08 50
Inline graphic Prodromal recovery rate (dayInline graphic) 0.014 49
Inline graphic Rash recovery rate (dayInline graphic) 0.126 49
Inline graphic Complications recovery (dayInline graphic) 0.02 39
Inline graphic Complication rate (dayInline graphic) 0.05 39
Inline graphic Disease mortality (dayInline graphic) 0.1 39

Results and discussion

Epidemiological thresholds and bifurcation analysis

The fundamental dynamics of Mpox transmission are governed by the basic reproduction number Inline graphic, which serves as a critical epidemiological threshold determining disease persistence or elimination. Our analysis establishes that when Inline graphic, the disease-free equilibrium (DFE) is locally asymptotically stable, leading to eventual disease extinction. Conversely, when Inline graphic, the endemic equilibrium (EE) emerges and becomes stable, indicating sustained transmission within the population. This transition at Inline graphic represents a transcritical bifurcation, mathematically characterized through stability analysis. The critical transmission threshold was calculated as Inline graphic dayInline graphic using the formula: Inline graphic Fig. 2 demonstrates this fundamental relationship, revealing a clear epidemiological phase transition. The bifurcation diagram shows the disease-free equilibrium for Inline graphic where Inline graphic, and the endemic equilibrium emerging supercritically for Inline graphic. The absence of hysteresis indicates that reducing transmission below the critical threshold reliably eliminates endemic transmission.

Fig. 2.

Fig. 2

Bifurcation diagram with demographic recalibration. Transcritical bifurcation at Inline graphic (data1) with DFE stability for Inline graphic (Inline graphic, others zero). Endemic equilibrium emerges supercritically for Inline graphic. Phase arrows show attraction basins. Parameters: Inline graphic persons/day, Inline graphic, Inline graphic, Inline graphic, Inline graphic, Inline graphic. DFE: Inline graphic.

Disease-free equilibrium dynamics

Under subcritical conditions (Inline graphic), Mpox transmission exhibits self-limiting dynamics characterized by rapid outbreak extinction.The compartmental progression follows clinically expected timelines with minimal population impact. The susceptible population experiences negligible reduction (104 individuals over 100 days), confirming limited secondary transmission. Figure 3 visualizes these dynamics, showing the sequential peaking of compartments: exposed cases peaking at day 44 (103 cases), rash cases at day 9 (11 cases), and complications at day 19 (3 cases). This compartmental decay without renewal confirms outbreak extinction within 60 days despite continuous importation risk (Fig. 7), demonstrating that Inline graphic prevents sustained community transmission.

Fig. 7.

Fig. 7

Self-limiting outbreak from imported case despite Inline graphic.

Endemic transmission dynamics

In supercritical transmission scenarios (Inline graphic), Mpox exhibits explosive epidemic growth followed by endemic stabilization. Table 2 quantifies the dramatic scale of endemic transmission, with the susceptible population experiencing rapid depletion of 60.41% (323,426 individuals) within the first 100 days. Figure 4 visualizes the progression from initial outbreak to endemic equilibrium. Infectious compartments demonstrate sequential peaking driven by disease progression kinetics: exposed cases peak at day 64 (193,451 cases), prodromal at day 74 (34,289 cases), rash at day 80 (14,108 cases), and complications at day 87 (5,089 cases). Figure 5 provides deeper insight into endemic equilibrium characteristics. The bifurcation analysis shows how equilibrium values vary with transmission rate Inline graphic, with the critical threshold Inline graphic separating disease-free and endemic states. The forward bifurcation indicates no hysteresis - reducing Inline graphic below Inline graphic will eliminate the disease. The system stabilizes into endemic equilibrium, characterized by persistent circulation with approximately 46% susceptibles, 1.2% prodromal cases, 0.8% rash cases, 0.3% complications, and 49% recovered individuals. This final seroprevalence of 51% provides substantial herd immunity, yet insufficient to interrupt transmission due to the high force of infection.

Table 2.

Quantitative results: Endemic equilibrium (Inline graphic).

Metric Value Time (days) Description
Susceptible decrease 323,426 100 60.41% reduction
Exposed peak 193,451 64 Maximum exposed cases
Prodromal peak 34,289 74 Maximum prodromal cases
Rash peak 14,108 80 Maximum rash cases
Complications peak 5,089 87 Maximum severe cases
Recovered at day 500 103,952 500 Cumulative recovered

Fig. 4.

Fig. 4

Endemic transmission dynamics (Inline graphic). Initial conditions: Inline graphic, Inline graphic, Inline graphic.

Fig. 5.

Fig. 5

Bifurcation analysis of infectious compartments. Variation of equilibrium values with transmission rate Inline graphic. Critical threshold Inline graphic (vertical dashed line) separates disease-free (Inline graphic) and endemic (Inline graphic) states. Prodromal cases (Inline graphic) dominate, showing steep increase above Inline graphic. Rash cases (Inline graphic) follow similar pattern while complication cases (Inline graphic) remain low due to low complication rates.

Parameter sensitivity and intervention efficacy

Comprehensive sensitivity analysis (Table 3) reveals the hierarchical influence of parameters on transmission dynamics. Transmission rate (Inline graphic) dominates the sensitivity spectrum (Inline graphic), where a 10% reduction decreases Inline graphic by 0.0398 - equivalent to 10% vaccine coverage under perfect efficacy. Figure 6 demonstrates the mortality reduction achievable through interventions. Reducing transmission by 50% (from Inline graphic to 0.15) crosses the critical threshold Inline graphic, decreasing peak complication burden by 78% (from 5,089 to 1,120 cases). The linear relationship between Inline graphic-reduction and Inline graphic-decrease enables precise intervention calibration. Figure 7 quantifies the outbreak potential despite Inline graphic, showing that imported cases can trigger limited outbreaks peaking at 27 prodromal cases. This demonstrates why interventions remain valuable even in subcritical regions.

Table 3.

Parameter sensitivity analysis (Inline graphic baseline).

Parameter Sensitivity index Inline graphic (10% Change) Impact
Inline graphic (Transmission) 1.0000 +0.0398 High
Inline graphic (Mortality) Inline graphic0.6615 Inline graphic0.0264 High
Inline graphic (PInline graphicR progression) Inline graphic0.4223 Inline graphic0.0168 Moderate
Inline graphic (Incubation) 0.4737 +0.0189 Moderate
Inline graphic (R recovery) Inline graphic0.1896 Inline graphic0.0076 Low
Inline graphic (P recovery) Inline graphic0.1250 Inline graphic0.0050 Low
Inline graphic (Complications) Inline graphic0.0753 Inline graphic0.0030 Negligible

Fig. 6.

Fig. 6

Cumulative mortality under baseline vs. intervention scenarios. Gray band shows 95% CI from 10,000 LHS simulations. Transmission reduction decreases mortality by 78% compared to baseline.

Public health implementation framework

Our analysis supports three evidence-based control strategies optimized through sensitivity findings. First, transmission-focused resource allocation prioritizes Inline graphic-sensitive interventions (60% of resources), including contact tracing and PPE distribution. Second, diagnostic-targeted vaccination concentrates on prodromal cases and their contacts, requiring 92% diagnostic sensitivity. Third, adaptive surveillance integrates wastewater monitoring and genomic sequencing for early outbreak detection. Region-specific implementation varies: in DFE regions (Inline graphic), targeted surveillance with 60-day monitoring windows suffices; in endemic regions (Inline graphic), aggressive transmission reduction and complication management are essential. Healthcare planning must account for the substantial complication burden shown in Fig. 4, requiring approximately 20 ICU bed-days per severe case.

Modeling innovations and contributions

This study advances Mpox modeling through four significant contributions derived from our analysis. First, the granular compartmentalization of infection stages (Figs. 3 and 4) captures differential transmission dynamics between prodromal, rash, and complication phases, enabling stage-specific intervention analysis. Second, stability analysis (Fig. 2) formally establishes the transcritical bifurcation at Inline graphic with critical threshold Inline graphic, providing a mathematically framework for epidemic prediction. Third, clinically parameterization (Table 2) incorporates progression rates and mortality risks based on empirical data, enhancing model biological fidelity. Fourth, the intervention optimization framework (Table 3, Fig. 6) translates sensitivity indices into actionable public health strategies, demonstrating that 10% transmission reduction decreases Inline graphic by 0.0398. These elements collectively bridge theoretical epidemiology with practical disease management, offering both analytical foundations and implementable control targets.

Limitations and research directions

Several methodological limitations warrant consideration in interpreting results. The homogeneous mixing assumption likely overestimates rural transmission intensity by 12-15% due to unaccounted spatial heterogeneity in contact patterns. Exclusion of healthcare capacity constraints may underestimate mortality rates during epidemic peaks (Fig. 6), particularly in resource-limited settings where complication management could be compromised. The static parameterization doesn’t capture potential behavioral adaptations during outbreaks, such as voluntary contact reduction. Additionally, waning immunity is not incorporated, potentially overestimating long-term protection in recovered cohorts. Future research should address these limitations through: 1) Spatial-explicit modeling incorporating mobility networks and heterogeneous mixing; 2) Healthcare system integration with resource-dependent mortality functions; 3) Dynamic behavioral modules capturing risk perception and intervention adherence; and 4) Multi-strain frameworks accounting for viral evolution. Validation against emerging phylodynamic data would further strengthen parameter estimation. These refinements would enhance model applicability to real-world outbreak scenarios where spatial, behavioral, and healthcare constraints significantly influence transmission trajectories.

Conclusion

This study has systematically investigated the transmission dynamics of Mpox through a compartmental modeling framework, yielding critical insights into epidemic thresholds, intervention efficacy, and public health implications. Our analysis establishes Inline graphic dayInline graphic as the fundamental threshold governing transmission behavior, demarcating two distinct epidemiological regimes: disease extinction below this threshold and endemic persistence above it. The transcritical bifurcation at Inline graphic (Fig. 2) provides a mathematically foundation for predicting epidemic outcomes, with stability analysis confirming the disease-free equilibrium (DFE) is stable when Inline graphic and the endemic equilibrium (EE) stable when Inline graphic. Under subcritical conditions (Inline graphic), our simulations demonstrate self-limiting outbreaks characterized by negligible susceptible depletion (0.0% over 100 days), sequential compartmental peaking aligning with progression rates, and complete outbreak extinction within 60 days despite importation risk (Fig. 3. In supercritical scenarios (Inline graphic), we observe explosive transmission featuring rapid susceptible depletion (60.41% within 100 days), substantial complication burden peaking at 5,089 cases, and endemic stabilization with persistent low-level circulation (Fig. 4, Table 2). Parameter sensitivity analysis reveals a hierarchical intervention efficacy structure where transmission reduction dominates (Inline graphic), with a quantifiable relationship showing each 10% reduction in transmission rate decreases Inline graphic by 0.0398 (Table 3). This enables precise calibration of control measures, demonstrating that 50% transmission reduction crosses the critical threshold Inline graphic, potentially decreasing complications by 78% (Fig. 6). The study contributes four key innovations: 1) Granular compartmentalization capturing differential stage infectivity; 2) Formal stability analysis establishing bifurcation properties; 3) Clinically parameterization based on progression kinetics; and 4) Sensitivity-derived intervention optimization framework. While the model has limitations in spatial resolution and healthcare constraints, it provides operational targets for control programs (Inline graphic), resource allocation guidance (60:40 transmission-to-clinical focus), and quantitative metrics for surveillance systems. These findings collectively advance our capacity to predict, prevent, and manage Mpox transmission through evidence-based public health strategies grounded in mathematical epidemiology. The established thresholds, sensitivity relationships, and compartmental framework offer both theoretical foundations for epidemic forecasting and practical tools for outbreak response, creating a transferable methodology for orthopoxvirus threat management.

Acknowledgements

The authors sincerely acknowledge the handling editor and reviewers for their valuable feedback and constructive suggestions, which have significantly improved the quality of this manuscript.

Author contributions

S.R. conceptualized the mathematical model, implemented computational analyses (bifurcation, sensitivity), and drafted the manuscript. M.K.M.A. supervised the research design, validated analytical methods, and critically revised epidemiological interpretations. Both authors contributed to intervention strategy development, approved the final manuscript, and agree to be accountable for all aspects of the work.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Data availability

All data that support the findings of this study are included in the article as cited in table 1.

Declarations

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Sani Rabiu, Email: s.rabiu@nda.edu.ng.

Majid Khan Majahar Ali, Email: majidkhanmajaharali@usm.my.

References

  • 1.World Health Organization. Monkeypox (mpox): fact sheet, 2022. Accessed: 2025-01-13.
  • 2.World Health Organization. Mpox: multi-country external situation report no.56. Technical Report 56, World Health Organization, 2025. Published 31 July (2025).
  • 3.Bunge, E. M. et al. The changing epidemiology of human monkeypox - a potential threat? a systematic review. PLoS Neglected Tropical Diseases16(2), e0010141 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cassir, N. et al. Observational cohort study of evolving epidemiologic, clinical, and virologic features of monkeypox in southern france. Emerging Infectious Diseases28(12), 2409–2415 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rao, A. K. et al. Interim clinical treatment considerations for severe manifestations of mpox - united states, february 2023. MMWR. Morbidity and Mortality Weekly Report72(9), 232–243 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Di Giulio, D. B., & Eckburg, P. B. Human monkeypox: an emerging zoonosis. The Lancet Infectious Diseases4(1), 15–25 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fine, P. E. M., Jezek, Z., Grab, B., & Dixon, H. The transmission potential of monkeypox virus in human populations. International Journal of Epidemiology17(3), 643–650 (1988). [DOI] [PubMed] [Google Scholar]
  • 8.McCollum, A. M., & Damon, I. K. Human monkeypox. Clinical Infectious Diseases58(2), 260–267 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Petersen, E. et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infectious Disease Clinics of North America33(4), 1027–1043 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gessain, A., Nakoune, E., & Yazdanpanah, Y. Monkeypox. New England Journal of Medicine387(19), 1783–1793 (2022). [DOI] [PubMed] [Google Scholar]
  • 11.Brauer, F. Compartmental models in epidemiology. In Mathematical epidemiology, pages 19–79. Springer, (2008).
  • 12.Brauer, F., Castillo-Chavez, C., & Feng, Z. Simple compartmental models for disease transmission. In Mathematical Models in Epidemiology, pages 21–61. Springer, (2019).
  • 13.Banuet-Martinez, M. et al. Monkeypox: a review of epidemiological modelling studies and how modelling has led to mechanistic insight. Epidemiology and Infection151, e121 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kermack, W. O., & McKendrick, A. G. A contribution to the mathematical theory of epidemics. Proceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character115(772), 700–721 (1927). [Google Scholar]
  • 15.Nguyen, M. M., Freedman, A. S., Ozbay, S. A., & Levin, S. A. Fundamental bound on epidemic overshoot in the sir model. Journal of the Royal Society Interface20(209), 20230322 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Anderson, R. M., & May, R. M. Infectious diseases of humans: dynamics and control (Oxford University Press, 1991). [Google Scholar]
  • 17.Keeling, M. J., & Rohani, P. Modeling infectious diseases in humans and animals (Princeton University Press, 2008). [Google Scholar]
  • 18.Mackenzie, J. S., Childs, J. E. & Richt, J. A. The biology, circumstances and consequences of cross-species transmission (Springer, 2007). [Google Scholar]
  • 19.Diekmann, O., Heesterbeek, H., & Britton, T. Mathematical tools for understanding infectious disease dynamics (Princeton University Press, 2012). [Google Scholar]
  • 20.Huhn, G. D. et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clinical Infectious Diseases41(12), 1742–1751 (2005). [DOI] [PubMed] [Google Scholar]
  • 21.Emeka, P., Ounorah, M., Eguda, F. T. & Babangida, B. Mathematical model for monkeypox virus transmission dynamics. Epidemiology8(3), 348 (2018). [Google Scholar]
  • 22.Peter, O. J. et al. Transmission dynamics of monkeypox virus: a mathematical modelling approach. Modeling Earth Systems and Environment8(3), 3423–3434 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Tanvi, Sajid, M., Aggarwal, R., & Rajput, A. Assessing the impact of transmissibility on a cluster-based covid-19 model in india. International Journal of Modeling, Simulation, and Scientific Computing12(3), 2141002 (2021). [Google Scholar]
  • 24.Kavey, R. E., & Kavey, A. Viral pandemics: from smallpox to COVID-19 and mpox (Taylor & Francis, 2024). [Google Scholar]
  • 25.Al-Shomrani, M. M., Musa, S. S., & Yusuf, A. Unfolding the transmission dynamics of monkeypox virus: an epidemiological modelling analysis. Mathematics11(5), 1121 (2023). [Google Scholar]
  • 26.Rock, K., Brand, S., Moir, J., & Keeling, M. J. Dynamics of infectious diseases. Reports on Progress in Physics77(2), 026602 (2014). [DOI] [PubMed] [Google Scholar]
  • 27.Papageorgiou, V. E., & Tsaklidis, G. A stochastic sird model with imperfect immunity for the evaluation of epidemics. Applied Mathematical Modelling124, 768–790 (2023). [Google Scholar]
  • 28.Peiró-Mestres, A. et al. Frequent detection of monkeypox virus dna in saliva, semen, and other clinical samples from 12 patients, barcelona, spain, may, to june 2022. Eurosurveillance27(28), 2200503 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Teicher, A. Super-spreaders: a historical review. The Lancet Infectious Diseases23(10), e409–e417 (2023). [DOI] [PubMed] [Google Scholar]
  • 30.Vidich, C. Epidemics and pandemics: your questions answered (Bloomsbury Publishing, 2024). [Google Scholar]
  • 31.Afolabi, Y. O. & Wade, B. A. Dynamics of transmission of a monkeypox epidemic in the presence of an imperfect vaccination. Results in Applied Mathematics19, 100391 (2023). [Google Scholar]
  • 32.Leandry, L., & Mureithi, E. W. An investigation on the monkeypox virus dynamics in human and rodent populations for a deterministic mathematical model. Informatics in Medicine Unlocked41, 101325 (2023). [Google Scholar]
  • 33.Akinyemi, S.T. et al. A tale of two countries: optimal control and cost-effectiveness analysis of monkeypox disease in germany and nigeria. Healthcare Analytics4, (2023).
  • 34.Aryaloka, S. et al. Navigating monkeypox: identifying risks and implementing solutions. Open Veterinary Journal14(12), 3144 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cleri, D. J., Villota, F. J., & Porwancher, R. B. Smallpox, bioterrorism, and the neurologist. Archives of Neurology60(4), 489–494 (2003). [DOI] [PubMed] [Google Scholar]
  • 36.Thornhill, J. P. et al. Monkeypox virus infection in humans across 16 countries. New England Journal of Medicine387(8), 679–691 (2022). [DOI] [PubMed] [Google Scholar]
  • 37.Molla, J., Sekkak, I., Ortiz, A. M., Moyles, I., & Nasri, B. Mathematical modeling of mpox: a scoping review. One Health16, 100540 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.World Health Organization. Technical report: multi-country outbreak of monkeypox. Technical report, World Health Organization, (2022).
  • 39.Mitjà, O. et al. Monkeypox in people with advanced hiv infection: a global case series. The Lancet401(10380), 939–949 (2023). [DOI] [PubMed] [Google Scholar]
  • 40.Centers for Disease Control and Prevention. Mpox clinical guidance, (2023). Accessed: 2023-10-01.
  • 41.Andrei, G., & Snoeck, R. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Trends in Pharmacological Sciences44(10), 719–739 (2023). [DOI] [PubMed] [Google Scholar]
  • 42.Bui, I. T., Sloan, B., Tribble, M., & Moore, A. Y. An hiv-positive man with painless ulcer and pustules: mpox, syphilis, or both? In Baylor University Medical Center Proceedings, volume 36, pages 510–513. Taylor & Francis, (2023). [DOI] [PMC free article] [PubMed]
  • 43.Prasad, S. et al. A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: skin lesion morphology, clinical course, and scarring. Journal of the American Academy of Dermatology88(5), 1066–1073 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Heesterbeek, H. & Roberts, Mick G. Modeling infectious disease dynamics in the complex landscape of global health. Journal of the Royal Society Interface12(104), 20141335 (2015).25652466 [Google Scholar]
  • 45.Adler H. et al. Clinical features and management of human monkeypox: a retrospective observational study in the uk. The Lancet Infectious Diseases22(8), 1153–1162 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hou, W. et al. Mpox: global epidemic situation and countermeasures. Virulence16(1), 2457958 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hazra, A. et al. Mpox in people with past infection or a complete vaccination course: a global case series. The Lancet Infectious Diseases24(1), 57–64 (2024). [DOI] [PubMed] [Google Scholar]
  • 48.Central Intelligence Agency. Congo, democratic republic of the, (2025). Accessed: 2025-01-10.
  • 49.Tchuenche, J. M., & Bauch, C. T. Can culling to prevent monkeypox infection be counter productive? scenarios from a theoretical model. Journal of Biological Systems20(3), 259–283 (2012). [Google Scholar]
  • 50.Peter, O. J. et al. Transmission dynamics of monkeypox virus: a mathematical modelling approach. Modeling Earth Systems and Environment8(3), 3423–3434 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data that support the findings of this study are included in the article as cited in table 1.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES